Results 11 to 20 of about 19,034 (221)

NAFLD‐related hepatocellular carcinoma: The growing challenge

Hepatology, EarlyView., 2022
Risk and protective factors for NAFLD‐related hepatocellular carcinoma Abstract Hepatocellular carcinoma (HCC) is a common cause of cancer‐related mortality and morbidity worldwide. With the obesity pandemic, NAFLD‐related HCC is contributing to the burden of disease exponentially.
Pir Ahmad Shah, Rashmee Patil, Stephen A. Harrison   +2 more
wiley   +1 more source

Health disparities in chronic liver disease

Hepatology, EarlyView., 2022
Abstract The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Health disparities occur when plausibly avoidable health differences are experienced by socially disadvantaged populations.
Ani Kardashian, Marina Serper, Norah Terrault, Lauren D. Nephew   +3 more
wiley   +1 more source

Resistance Mutations A30K and Y93N Associated with Treatment Failure with Sofosbuvir and Daclatasvir for Hepatitis C Virus Infection Non-Responder Patients: Case Reports

Viruses, 2019
In Brazil, hepatitis C treatment has been evolving significantly with the licensing of direct-acting antivirals (DAAs). However, viral determinants (amino acid substitutions in hepatitis C virus (HCV) genome and infective genotype) associated with host ...
Vanessa D. Costa, Patricia Pellegrini, Vivian Rotman, Ana Maria Pittella, Estevão P. Nunes, Barbara V. Lago, Elisabeth Lampe, Francisco C. A. Mello   +7 more
doaj   +1 more source

Prevalence of Active HCV Infection in Spain in 2022 Using Multiparameter Evidence Synthesis. [PDF]

J Viral Hepat
ABSTRACT Hepatitis C virus (HCV) remains a major public health concern worldwide. Spain has implemented large‐scale direct‐acting antiviral (DAA) treatment programs, yet the prevalence of active HCV infection (aHCV) and its trends over time remain incompletely characterised.
Thomadakis C, Gountas I, Gountas K, Nuño N, Brime B, Sendino R, Albillos A, Buti M, Crespo J, Berenguer J, Alonso S, de Santiago AD, Hernando V, Laguno M, Lens S, Diago M, Montes ML, García-Samaniego J, Morano L, Moreno JL, Navarro J, Romero-Gómez M, Santos L, Soriano R, Duffell E, Diaz A, Del Amo J, Nikolopoulos G.   +27 more
europepmc   +2 more sources

Effects of antiviral therapy on reducing the risk of metabolic syndrome in patients with chronic hepatitis C

Журнал инфектологии, 2023
Aim – to evaluate the effect of direct antiviral drugs (sofosbuvir and velpatasvir) on the formation of the metabolic syndrome in patients with chronic hepatitis C with a high risk of its development 2 years after treatment.Materials and methods.
A. F. Novikova, D. A. Kokorev, D. Yu. Konstantinov, L. L. Popova   +3 more
doaj   +1 more source

Virological and Clinical Outcome of DAA Containing Regimens in a Cohort of Patients in Calabria Region (Southern Italy)

Medicina, 2020
Background and objectives: In Italy, Hepatitis C Virus (HCV) infections are most prevalent in people older than 50 years of age, who often experience multi-morbidities, take co-medications, and have a long history of liver disease.
Vincenzo Scaglione, Maria Mazzitelli, Chiara Costa, Vincenzo Pisani, Giuseppe Greco, Francesca Serapide, Rosaria Lionello, Valentina La Gamba, Nadia Marascio, Enrico Maria Trecarichi, Carlo Torti   +10 more
doaj   +1 more source

Privacy Model and Annotation for DaaS [PDF]

2010 Eighth IEEE European Conference on Web Services, 2010
Data as a Service (DaaS) builds on service-oriented technologies to enable fast access to data resources on the Web. However, this paradigm raises several new concerns that traditional privacy models for Web services do not handle. First, the distinction between the roles of service providers and data providers is unclear, leaving the latter helpless ...
Mrissa, Michael, Tbahriti, Salah-Eddine, Truong, Hong-Linh   +2 more
openaire   +1 more source

Real-Life Data of Chronic Hepatitis C Patients Treated with Direct-Acting Oral Antivirals: A Single-Center Study

İstanbul Medical Journal, 2023
Introduction:Chronic hepatitis C virus (HCV) infection is one of the important causes of liver cancer and cirrhosis all over the worldwide.Methods:The data of the patients diagnosed with chronic hepatitis C infection who applied to the Adult Infectious ...
Umut Devrim Binay, Faruk Karakeçili, Orçun Barkay, Özlem Gül   +3 more
doaj   +1 more source

Comparison of Anterior and Lateral Approach in Hip Hemiarthroplasty for Femur Neck Fractures in the Elderly: Clinical and Radiographic Outcomes [PDF]

Malaysian Orthopaedic Journal, 2022
INTRODUCTION: Many surgical approaches have been described for hip hemiarthroplasty (HHA) treating femur neck fractures (FNFs). Direct lateral approach (DLA) is one of the most used.
Faggiani M, Risitano S, Rissolio L, Baroni C, Alberghina F, Conforti L   +5 more
doaj   +1 more source

Non-invasive quantification of liver fibrosis regression following successful treatment of chronic hepatitis C with direct acting antivirals

Romanian Journal of Laboratory Medicine, 2017
Introduction. The past years have revolutionized the treatment of hepatitis C virus (HCV) infection, with high rates of sustained virologic response (SVR). Furthermore, liver fibrosis has recently been redefined as a dynamic, reversible process. Methods.
Nițescu Maria, Vâjâitu Cristina, Săndulescu Oana, Streinu-Cercel Adrian, Pițigoi Daniela, Preoțescu Liliana Lucia, Streinu-Cercel Anca   +6 more
doaj   +1 more source